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Natural killer activity in kidney allograft recipients and in uremic
hemodialyzed patients: In vitro effect of alfa-interferon. C. Ausiello, M.
Va/en, A. Piazza, D. Adorno, B. Evangelista, and CU. Casciani,
Instiluto di V' Patologia Chirurgica, Universitd, Rome, Italy. Several
data indicate that natural killer (NK) cells may play a role, in vivo,
against the outgrowth of malignant cells. Interferon (IFN) is the most
conspicuous regulatory agent capable of increasing NK activity. The
aim of this work was to analyze the spontaneous and IFN-induced NK
activity both in corticosteroid-treated kidney allograft recipients where
a significantly higher risk of malignancies is present and in uremic
hemodialyzed patients which show an aspecific immunodepression.
NK activity on 51-Cr labeled K562 target cells was studied in 19
functioning allograft recipients. The time that elapsed between the graft
and the test varied from 4 days to 13 years. Several patients were tested
more than once. Eighteen hemodialyzed and 18 normal individuals were
also studied. Spontaneous NK cytotoxicity was decreased sharply after
the graft. Depression or lack of NK activity was also observed in short-
term transplantation (< I month), while long-term transplantations (> 2
years) showed a tendency toward normal values. The IFN relative
enhancement of NK activity was the same as in control group, but the
total activity was still lower, suggesting that the few NK cells are
normally responsive at the IFN regulatory effect. The spontaneous and
IFN-induced NK activity of hemodialyzed patients was not significant-
ly different from the healthy control group, suggesting that renal
function is not involved with NK activity.
Charcoal hemoperfusion in chronic uremia: 5 years of clinical applica-
tion. V. Bonomini, S. Stefoni, G. Feliciangeli, M. P. Scolari, A.
Buscaroli, G. Mosconi, R. Prandini, and L. Co/i. Istituto di Nefrologia
e Dial isi, Universitd, Bologna, Italy. The capacity of charcoal to absorb
endogenous and exogenous toxins from the blood is well known. The
major drawbacks to its wide use in chronic uremia have been poor
biocompatibility and incapacity of absorbing urea, electrolytes, and
water. The two problems have been solved by (1) coating the charcoal
granules with highly biocompatible membranes and (2) using charcoal
hemoperfusion in conjunction with hemodialysis (HD/HP programs).
The first step in our experience was to evaluate biocompatibility.
tolerance, and efficiency of a new hemoperfusion device. Subsequently,
in a 5-year period we treated 33 patients according to the HD/HP
program (about 2,000 procedures). Two main groups of patients have
been included in the study: group A, 19 patients with persisting signs of
uremia despite adequate and even intensive dialysis treatment (mainly
recurring pericarditis, severe peripheral neuropathy, and pruritus) —
combined HD/HP treatment led to improvement of symptoms in 70% of
the patients, subjective and objective; group B, 14 patients, (residual
2.1 0.9 mi/mm; mean diuresis 280 ml) in good clinical and metabolic
condition. In these patients the combining of the sorption capacity of
dialysis and hemoperfusion allowed a reduction of the dialysis time, up
to the elimination of one entire procedure, for 3 to 26 months (mean,
10.7 67). Patients' clinicometabolic conditions serially checked
remained stable despite the one-third reduction in time of treatment,
while personal and social rehabilitation markedly improved.
Hyperparathyroidism as cofactor of uremic myopathy: An alternative
hypothesis. D. Brancaccio, F. Come/jo, F. Dwor:ak, L. Morandi, G.
Como, C. Galmozzi, M. Gioventu, and 1. Poletti. Servizio di Nefrolo-
gia, Ospedali S. Pao/o, Milano e Maggiore. Bergamo; Istituto Neurolo-
gico C. Besta, Milano; Divisione di Cardiologia, O.spedale S. Paolo,
Milano, Italy. Uremic patients undergoing regular dialytic treatment
(RDT) often present clinico-bioiogical signs of secondary hyperpara-
thyroidism; however, spontaneous high levels of blood calcium and
phosphate may be observed. This clinical status is called autonomous
hyperparathyroidism (iPTH-3) and actively involves bone structure and
several organs and apparatus as well. To clarify a possible relationship
between iPTH-3 and myopathy we performed muscle biopsy in three
patients affected by iP'rH-3 presenting evidence for a progressive distal
myopathy. One patient was also affected by a dilatative cardiomyopa-
thy. Muscle specimens (500 mg) were frozen immediately and the usual
battery of 14 histochemical and histoenzymatic reactions were per-
formed on 10-z serial sections. In addition, two selective staining
(alizarine red and glyoxal bis) were also performed to detect a possible
calcium deposition. The results in all patients evidenced a myopathy on
a neurological basis and, in addition, diffuse microgranular calcium
deposits in the arteriolar walls whose thickness was abnormally in-
creased; a wall contraction and a reduced vascular lumen were also
present. Muscle biopsy, performed 6 months after parathyroidectomy,
demonstrated in one patient the total disappearance of vascular depos-
its and a thinner aspect of vascular walls. A dramatic improvement of
his dilatative myocardiopathy was also observed. Our data seem to
suggest the following conclusions: (1) It is presumable the uremic
myopathy may also be due to ischemia secondary to reduced vascular
lumen; (2) the small and diffuse deposits in the muscolaris mucosa may
play a role in inducing the wall contraction; (3) as PTH can alter the
calcium intra/calcium extracellular ratio, it is to be considered a real
uremic toxin in terms of muscle tissue damage; (4) in patients on RDT a
parathyroidectomy may also be indicated for a better control of a
complex syndrome in which not necessarily bone tissue is mainly
involved.
T cell subsets monitoring in renal transplantation: A statistical ap-
proach. B. Brando, G. Civati, M. L. Broggi. C. Grub, A. Perego, C.
Guastoni, G. Busnach, A. F. Minetti, and L. Minetti. Divisione di
Nefrologia, Ospedale Niguarda-Ca' Granda, Milano. Italy. We serially
monitored 64 renal transplant recipients to study the patterns of T cell
subset numbers and functions in different clinical situations. The
patients were given: ATG (Immossar, Choay) 700 lU/kg/day for the first
15 days, then twice a week for another month, tapering steroids and
azathioprine. T cell subsets were determined by Orthomune monoclo-
nal antibodies. T suppressor function was studied by the Con-A
enhancement test and the blastogeneic response to mitogens was
measured. The normal trends of immunologically quiescent patients
were evaluated at first (TAB I).
TAB 1. Linear regressions of uncomplicated patients within l2
weeks.
T3% y = 40 + l.9x r = 0.36 P < 0.001
T4% y = 24 + l.6x r 0.39 P < 0.001
T8% y 24 — PNS
T4/T8 y = I + 0.09x r = 0.44 P < 0.001
T supp. activ. y = 59 — 1.3x r = —0.4 P < 0.005
Mitogen resp. y = 15100 + 7700x r = 0.51 P < 0.001
Acute rejection episodes were treated with steroid pulses and ATG
During IS rejections the following changes were observed (TAB 2).
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TAB 2. prerej. Crisis onset Rej. treatment
T4/T8 1.54 0.83 2.75 1.236 0.94 0.56'
T4/T3% 53.4 13.8 66.! 15.4a 42.4 23'
T8/T3% 38.3 18.2 23.6 9.8b 54.7 22.1'
T supp. activ. 57.9 25.4
aP<002 b 20.1<0.01 18b'P<0.001 21.9 20.1
The frequency distribution of the T41T8 ratio between rejection and
quiescence was as follows (TAB 3).
TAB 3. Rejection Quiescence
T4/T8 < 1.800 2 (13.4%) 134 (76.6%)
T4/T8 1.800 13 (86.6%) 41(23.4%)
x2 = 27.158 P < 0.0005
The T suppressor activity remained low about 4 weeks after a rejection
episode. During bacterial infections, the T4/T8 ratio was usually high,
especially after the first 4 weeks (P < 0.01). During documented viral
infections, the T4/T8 ratio was low and often less than 1. FIBs Ag
positive patients, otherwise uncomplicated, displayed lower T4/T8
ratios than negative ones (P < 0.0025). No particular clinical and
laboratory changes were observed in patients receiving prophylactic
cimetidine. These findings were discussed.
Defective T-suppressor activity in type I membranoproliferative gb-
merubonephritis (MPGN-I). G. Busnach, S. Bertoli, A. Fornasieri, R.
Sinico, G. Fiorini, C. Guastoni, G. Barbiano di Belgiojoso, M. G.
Lava gni, and B. Brando. Divisioni di Nefrologia, Ospedali Niguarda-
Ca' Granda e S. Carlo Borromeo, and Banca del Sangue, Ospedale S.
Carlo Borromeo, Milano, Italy. T-cell subsets have been so far reported
to be normal in MPGN. To investigate T-suppressor cell (Ts) activity,
12 patients with histologic diagnosis of MPGN-I have been studied: 6
males and 6 females; mean age, 37 16.5 years. All patients had normal
renal function; proteinuria did not exceed 2 g/24 h, and none had
received immunosuppressive treatment during the year before. Dura-
tion of illness was 4 to 132 months. In 7 out of 12 serum C3 and/or C4
was low; CH5O was reduced in 6 out of 12 and an alternative pathway
involved in 4 out of 12. Circulating immune complexes (S.P. conglutinin
assay) were present in 2 out of 12. IgG were high in 5 out of 12 and low
in 3 out of 12. T-cell subsets were analyzed by monoclonal antibodies of
the OKT series. Ts function (TsF) was studied by the Con-A enhance-
ment test (Con-A E) and with a specially designed assay where the
response to pokeweed mitogen (PWM) is measured before and after
physical OKT8+ cell removal by complement-mediated cell toxicity
assay. In Table 1, MPGN-I patients are considered as a group, and in
Table 2 normo (N) and hypocompleinentemic (H) patients are
compared.
Table I
The low OKT4/OKT8 ratio is due to a relative increase of OKT8+ cells
(P < 0.05) and also to a reduction of OKT4+ cells in H patients (P <
0.005). TsF as studied with a specific OKT8+ cell-dependent test
enabled us to detect a highly significant defect in MPGN-I, whereas
Con-A E test, which is not strictly T-cell dependent. was unchanged.
There is a discrepancy between T-cell subsets markers and T-cell
functional activity: An increase of OKT8± may obviate to their
functional failure. Hypocomplementemia could be a marker of a
defective TsF in MPGN-I, which is not affected by the duration of
illness in patients with normal renal function and without nephrotic
syndrome.
Epithelial polyanionic coat and changes of foot processes in courses of
nephrotic syndrome in humans. S. Casanova, U. Donini, P. Versura,
and P. Zucchelli. Laboratorio Microscopia Elettronica e Servizio
Anatomia Patologica, Divisione di Nefrologia e Dia/isi, Ospedale M.
Malpighi, Bologna, Italy. Recent experimental studies on nephrotic
syndrome presented the following data. The alterations of the glomeru-
lar epithelium seem to be correlated with the reduction of surface
epithelial anionic charges. We studied, by light and electron microsco-
py, the affinity of the glomerular epithelium for colloidal iron on renal
biopsy specimens of 12 patients with nephrotic syndrome. Six patients
were suffering from membranous glomerulonephritis and the others had
minimal change glomerulonephritis. In each patient we compared the
degree of colloidal iron reaction with that of foot process fusion and
with proteinuria. The colloidal iron reaction was carried out at pH 1.9.
For electron microscopy 20-i.e thick cryostat sections were briefly fixed
then treated with colloidal iron thereafter postfixed with osmium and
embedded in epoxy resins. For light microscopy cryostat sections of 4
to 6 jz were fixed in aceton for 5 mm and then incubated in the colloidal
iron solution. The presence of colloidal iron was evidenced through
Prussian blue reaction. The control sections were prepared from an
undamaged kidney portion obtained by a nephrectomy. By light micros-
copy, the reaction appeared to weaken in patients in which proteinuria
was higher than 40 to 60 mg/mq/hr. By electron microscopy the reaction
appeared unmodified even in the presence of a complete fusion of the
foot processes and massive proteinuria. The weakened reaction for
colloidal iron observed by light microscopy resulted from the reduction
of the epithelial surface area caused by the foot process fusion. These
data suggest that the colloidal iron reaction is not sufficiently sensitive
to reveal small alterations of the surface epithelial charges.
Renal hypercalciuria (RH) and primary hypoparathyroidism (PH):
Evidence for a common defect in distal tubular calcium reabsorption
(TRCa). G. Colussi, F. Ma/bern, M. Surian, A. Antonacci, A. Marni,
G. Rombold, G. Pontoriero, and L. Minetti. Divisione di Nefrologia,
Ospedale Niguarda-Ca' Granda, Milano, Italy. In previous studies we
have shown that patients with RH (that is, a "diet-independent" or
fasting type of idiopathic hypercalciuria) have normal tubular reabsorp-
tion (TRMg) of ultrafiltrable magnesium (UFMg) during fasting, while
fractional excretion of ultrafiltrable Ca (UFCa) is higher than normal,
indicating a reduced TRCa. The clearance ratio (C1UFCa/CIUFMg),
which was lower than I in normal people (N) and in a group of diet-
dependent hypercalciuric patients, was higher than 1 in all RH patients,
as has been observed by micropuncture studies in early distal tubular
fluid. Since Mg is poorly reabsorbed along the distal nephron (while
TRCa and TRMg are tightly bound in the proximal tubule and Henle's
loop), we suggested that hypercalciuria in RH is a consequence of
reduced TRCa along the distal nephron. To verify such a hypothesis,
we compared renal handling of UFCa and UFMg in 11 RH patients and
in 8 patients with PH (idiopathic in four and postsurgical in four) made
normocalcemic with either vitamin D (DHT in three patients. 25(OH)D5
in one patient) or calcium administration (iv. and/or p.o.) in four
patients.
Plasma values and filtered load per unit GFR of Ca and Mg, Mg
excretion (MgE) and fractional excretion of UFMg (FEMg) did not
differ in N, RH, and PH; Ca excretion (CaE), fractional excretion of
UFCa (FECa), and CIUFCa/CIUFMg ratio were similarly increased
both in RH and PH (range of the clearance ratio in N = 0.25 — 0.86, RH
= 1.03 — 2, PH = 0.96 — 3.5); cAMP excretion was high in RH (4.4
Suppression %
1(4/8 R4/3% R8/399 Con-A E PWM-8 + Dep.
CONTROLS 1.8 072 60.6 11.21 31.1 111.86 47.5 15 40.6 = 13.11
MPGN-1 .2 0.50 53.8 17.41 44.2 19.36 35.6 22.5 8.3 11.41
P <0.025 P: NS P <0.05 P.' NS P <0.005
Table 2
N-MPGN .6 0.44 68.4 15.89
H-MPGN 1.0 0.34 43.5 9.22
P < 0.01 P < 0.005
38.6 4.9 31.3 20.3 18.4 14.12
48.2 22.22 35.9 25.7 6.5 10.09
P.145 P.'NS P.'NS
PCa LFCa PM8 UFM0 CE.
vg1dI (1FR
N 9.32 4.93 2.00 1.24 68
3
RH 9,32 4.97 1.92 1.34 90'
100
PH 9.30 4.76 1.83 1.26 220"
P <0,00) vs. N
CIIJFCa
FE/Ca MgE FE/Mg -
'7/ 9g/dl GFR 99 CIUFMg
1.59 34 2.80 0.53
9
4.17' 38 2.66 .52'
9
4.84' 33 2.72 2.18'
±3.25 ±19 ±1,72 ±1.61
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1.6 nmoles/dI GFR, P <0.00! vs. N: 2.46 0.72) and low in PH (1.49
0.47, P < 0.001 vs. N). Renal phosphate threshold was high in PH (4.6
0.39 mg/dl GFR, P < 0.01 vs. N: 3.83 0.59) and low in RH (2.8
0.59, P < 0.001 vs. N). In conclusion, (I) patients with PH (in whom
PTH-dependent distal TRCa is reduced) kept normocalcemic and
normomagnesiemic, show fasting hypercalciuria with normal TRMg
and increased CIUFCaICIUFMg ratio; (2) the pattern of renal handling
of UFCa and UFMg is similar in RH and in PH and is consistent with a
reduced TRCa along the distal nephron in RH; (3) low distal TRCa in
RH is not due to a reduced parathyroid activity and could indicate
either a primary tubular defect or the effects of a mild phosphate
depletion state on the renal function.
Mechanism of impaired urinary concentration ability in chronic renal
failure (CRF). G. Conte, A. Dal Canton, G. Fuiono, M. Sabbatini, M.
Terribile, and V. E. Andreucci. Cattedra di Nefrologia, II do Focoltd di
Medicina, Universitd, Napoli, Ital. In this study, the mechanism(s) by
which urinary concentrating ability is impaired in CRF was investigated
in three groups of patients with GFR of 20 to 50 mI/mm. Group 1: Seven
normotensive patients were studied in maximal antidiuresis. The clear-
ance of creatinine (Cer), sodium, urea, and osmolar clearance (Cosm)
were measured while patients were receiving a normal dietary content
of sodium and protein (A) and after a 1-week administration of low-
sodium, low-protein diet (B). Group 2: The same clearance studies as in
group I were performed in 12 normotensive and 12 hypertensive
patients, both in antidiuresis and maximal water diuresis. In the latter
condition, distal sodium delivery (Nadf) could be calculated. Group 3:
Eight hypertensive patients were studied in antidiuresis before and after
drug-induced normalization of blood pressure. In group I, in (B) Ccr
was unchanged, fractional sodium excretion fell from 1.9 to 0.5%, and
the filtered load of urea was reduced by 40%. No significant modifica-
tion occurred in maximal urine osmolality (lJ,,,,,,), nor in T"H20. In
group 2, in antidiuresis, U,,,, TrH2O and TcH2O/C0,, were significant-
ly lower in hypertensive patients (P < 0.0!; P < 0.0125, and P < 0.05,
respectively). In water diuresis, instead, CH,I)/dl GFR was similar in
normotensives as hypertensives, despite that in the latter Na1 was
increased (P < 0.05). In group 3, normalization of blood pressure was
not associated with any change in U0,,. nor in T"HO. The results of
this study indicate that neither ECF volume expansion, or increased
nephron urea load play a critical role in reducing concentrating ability.
This defect is better accounted for by intrinsic tubular damage that is
enhanced in hypertensive patients.
IgA subclasses in circulating immune complexes, immunoglobulins and
renal deposits of Berger and Henoch-Schonlein glomerulonephritis. R.
Coppo, B. Basolo, G. Mazzucco, M. R. Buizomi, M. Messina, G.
Camussi, G. Barbiano, R. Costello, and G. Piccoli. Cattedra di
Nefrologia e Istituto Anatomia Patologica, Universitd, Torino; Divi-
sioni di Nefro/ogia e Diolisi, Ospedali S. Giovanni, Torino e Niguarda-
Co Granda, Milano, Italy. The analysis of the IgA subclasses in plasma
and renal tissue of patients affected by Berger and Henoch-Schonlein
glomerulonephritis (GN), allows some insights into the pathogenesis,
still controversial, of these nephropathies. IgAl- and lgA2-producing
cells are almost equally represented in normal mucosas, whereas
normal serum IgA contains 90% of IgAl and 0% of lgA2. Conflicting
data have been reported on kidney tissue. No parallel analyses of IgA
subclasses in IgA containing circulating immune complexes (IgAIC) or
in A immunoglobulins (IgA) have so far been presented. The authors
studied 31 Berger GN and 15 Henoch-Schönlein ON by investigating:
(I) IgAIC, IgAIIC, IgA2IC (original conglutinin solid phase assay); (2)
IgA, IgAl, IgA2 serum levels (immunoenzymatic assay) (3) polymeric
serum igA (reduction-alkilation test); (4) IgAl and IgA2 renal deposits
(indirect immunofluorescence) on 15 kidney biopsy specimens. In both
groups of patients mean serum IgAIC levels significantly greater (P <
0.01) than controls were observed, significantly higher in Henoch-
Schdnlein than in Berger GN (197 328 vs. 61 121 sg lgA aggr/ml;
normal value (NV) 6 9 g IgA aggr/ml). The correlation of these data
with clinical phases of activity was good. IgAIC significantly correlated
with the amount of microscopic hematuria (r = 0.26, P < 0.01). Mean
levels of IgAIIC and IgA2IC significantly greater than controls were
observed in both groups (Berger ON: IgAl IC 145 230 jvg IgA aggr/ml,
IgA2IC 158 184 Lg IgA aggr/ml; Henoch-Schönlein GN: IgAIIC 274
444 g IgA aggr/ml, IgA2IC 168 213 IgA aggr/ml; fly: IgAIIC 18
22 g IgA aggr/ml, IgA2IC: 17 33 g IgA aggr/ml). In the active
phase both IgAl and IgA2IC significantly increased in Berger ON,
whereas only IgAIIC increased in Henoch-Schonlein GN. The IgAl/
IgA2 ratio in immunoglobulins was found to be similar with controls in
either group of patients; it was not correlated with the IgAlIC/IgA2lC
ratio. An increase on polymeric IgA was observed in 30% of Berger ON
and in 50% of Henoch-Schönlein ON. Both IgAl and lgA2 were
represented in renal deposits: IgA2 deposits were heavy in 66% of the
patients. These data suggest that IgA contained in IgAIC and renal
deposits of Berger and Henoch-Schönlein GN are derived from mucosal
plasma cells, in agreement with experimental models.
Presence of J chain in mesangial immune deposits (MID) of IgA
nephropathy (IgANP). LI. Donini, S. Casanova, G. Maletta, and P.
Zucchelli. Divisione di Nefrologia e Diolisi e Laboratorio Microscopia
Eletironica, Servizio Anatomia Patologica, Ospedole M. Molpighi,
Bologna, Italy. The presence of J chain in MiD of IgANP was
investigated to identify polymeric igA through immunohistochemical
techniques. We studied renal biopsy specimens of 23 patients with
Berger nephropathy (BNP), two with Henoch-SchOnlein glomerulone-
phritis (HSGN) and two with IgA glomerulonephritis associated with
alcoholic cirrhosis (IgAGNAC). As controls we used 10 patients with
different nephropathies. Two with igO deposits.six with 1gM deposits,
and two without deposits. Before the immunohistochemical reaction,
all the kidney cryostat sections were treated for 20 mm at 4C with urea
6 M in glycine buffer 0.1 M, pH 3.2. Both goat and rabbit anti-i antisera
(Nordic, The Netherlands) were used. By immunofluorescence these
antisera were found to cross-react with lgG deposits in two control
patients. To eliminate this cross-reaction we absorbed the anti-J antise-
ra with purified human IgG. Ten patients, which we found to be J-
positive by indirect immunofluorescence, were also studied by a direct
immunofluorescence and peroxidase-antiperoxidase (PAP) method.
Comparing the results of these various techniques, we decided to use
PAP in our investigation. Our results indicate that J chain is present in
MID of 17 out of 23 patients of BNP, in both the patients of IgAGNAC,
in 1 out of 2 patients of HSON and in 5 out of 6 control patients with
1gM deposits. One control patient with a moderate degree of 1gM
deposits was J negative as were the remaining patients studied. The
patients with BNP were separated into two groups: J-positive and J-
negative. In comparing the clinical features of these groups, no signifi-
cant differences were found. However the duration of the disease at the
moment of biopsy was relatively shorter in the J-negative group. In fact
the mean was 30.8 months for the J-positive and only 12.7 in the i-
negative patients. Our results suggest that: (I) polymeric IgA are
present in MID of the majority of BNP (73.9%); (2) nevertheless, the
BNP could be caused even by monomeric IgA alone. This is most often
verified in the starting phases of the illness. One can make the
hypothesis that BNP, at the beginning of its natural history, is caused
by monomeric IgA and only at a later stage does polymeric IgA
intervene.
Role of monocytes in extracapillary glomerulonephritis (ON): Histo-
chemical study in 15 patients. F. Ferrorio, G. Cola sonti, A. Fornasieri.
R. Sinico, E. Schiafj'ino, S. Nova, ond G. D'Arnico. Divisione di
Nefrologia e Servizio di Anolomia Patologica, Ospedale S. Carlo
Borromeo, Milano, Italy. in studies concerning human and experimen-
tal ON, it has been shown recently that macrophages are involved
actively both in extracapillary and intracapillary proliferative changes.
To evaluate their presence in renal tissue and their possible role in
disease, we used the "nonspecific esterase (NSE)" method in kidney
biopsy sections from 15 patients affected by rapidly progressive ON
(RPON). Al! the patients presented circumferential crescents in 70% of
glomeruli (cellular in 12, fibrotic in 3). Nine patients presented primary
RPGN (six idiopathic, one postinfectious, one type II membranoproli-
ferative, and one anti-OBM ON) and six suffered from systemic
diseases (three SLE, three necrotizing angiitis). NSE-positive cells
were measured separately in the crescents and the glomerular tuft, and
expressed in the latter as the monocyte-index/glomerulus (Ml/O). A
number of NSE-positive cells was observed in all cellular crescents,
whereas they were completely absent in fibrotic ones. The multinuclear
giant cells of the crescents were strongly NSE-positive, confirming
their similarity (or identity) with monocyte-macrophage cells. The
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average MI/G was 5.6: It was significantly higher in patients with
cellular crescents than in patients which showed mainly fibrotic cres-
cents (6.6 vs. 1.9); as a whole, the MuG was also higher in glomeruli
with "active" crescents than in glomeruli without crescents (7.7 vs.
2.2). On the other hand, the average MuG was similar in primary and
systemic RPGN (6.7 and 6.4, respectively) and in patients with a
different immunofluorescence pattern (negative 6.8; linear 7.6; granular
6.4). Repeat biopsies were performed in two patients who presented a
favorable course, after 4 and 7 months, respectively: In these patients
NSE-positive cells were no longer evident either in crescents or the
glomerular tuft. In conclusion, our results strongly support experimen-
tal data on the "effector" role of monocyte-macrophages cells in the
morphogenesis of extracapillary and intracapillary proliferative lesions
in different forms of RPGN.
Complement (C) activation and factor VIII abnormalities in hemolytic-
uremic syndrome (HUS) in childhood. F. Ginevri, G. P. Tonini, A.
Carrea, M. Pecorara, P. G. Mori, F. Perfumo, and R. Gusmano.
ServizI di Nefrologia e Dialisi e di Ematologia-Oncologia, Istituto G.
Gaslini, Genova, Italy. In HUS C activation and more recently, Factor
VIII complex (FVIIIC) abnormalities have been reported. Several
hypothesis have been formulated for the understanding of C activation.
The possibility of a proteolytic activity being responsible for C activa-
tion has been examined in this study. In nine children, aged 7 to 12
months to 5 years, during an acute phase of HUS, we have determined
C3, C4, Clq, Cls, CS, C3act, and C3d by radial immunodiffusion,
circulating immune complexes (CIC) by immunoenzymatic method; C3
splitting activity; FVIIIC by one stage clotting method; FVIIIRAG by
Laurell electroimmuno assay; electrophoretic mobility of FVIIIRAG:
and plasma sepharose CL6B gel chromatography. The results are: C3d
increased in 8 out of 9 patients, C3 decreased in 4 Out of 9, C4 decreased
in 7 out of 9, Clq decreased in 2 out of 9, and C3act decreased in 4 out of
9; Cls and CS were in the normal range. There was no evidence of CIC
and C3 splitting activity. FVIIIRAG increased in 8 out of 9 and the ratio
FVIIIRAG/FVIIIC was greater than 1.5 in 6 out of 9. Abnormal,
symmetrical, more anodal FVIIIRAG electrophoretic mobility was
found in 7 out of 9 patients. In the same patients a disappearance or
reduction of high molecular weight forms (>4 x lO6D) has been
observed by plasma gel filtration studies. Our results show that in HUS
the activation of C occurs mainly via the classical pathway. In seven
patients FVIIIRAG fragmentation and C activation suggest the possibil-
ity of proteolytic activity acting on both systems.
T.lymphocyte subpopulations defined by monoclonal antibodies in
uremic patients on dialysis treatment. M. Mandreoli, M. Briganti, G.
Emiliani, A. Fabbri, L. Guernini, E. Magni, A. Montanan, G. Monti, F.
Lauria, and M. Fusaroli. Divisione di Nefrologia e Dialisi e Servizio di
Anatomia Patologica, Ospedale S. Maria Croci, Ravenna; Istituto di
Ematologia Seragnoli" Universitd, Bologna, Italy. Uremic patients
are thought to present a variety of immunologic abnormalities affecting
principally delayed hypersensitivity, homograft rejection, and T-cell
response to mitogens, while B-cell functions remain relatively unaffect-
ed. In this study, using monoclonal antibodies (MoAbs) of OKT series
(ORTHO), we evaluated the distribution of T-lymphocyte subsets in 23
patients on regular hemodialysis treatment (RDT) and in 10 patients on
intermittent peritoneal dialysis (PD). We also investigated the mitogenic
response to PHA. The aim of the work was to verify whether or not an














HD 66 62 42 22 2 45261
P < 0.001
PD 71 65 43 26 1.7 42300
P < 0.001
Controls 72 70 43 25 1.7 72588
The proportion and absolute number of T-lymphocytes (E and OKT3
cells) resulted in normal in both groups. The analysis of T-cell subsets
showed that both T-cells with helper/inducer (OKT4 cells) and sup-
pressor/cytotoxic (OKT8 cells) phenotype were in the range, with
OKT4/OKT8 ratio normally balanced. In contrast the in vitro prolifera-
tive response to PHA was reduced significantly in both patient groups
as compared to healthy controls (P < 0.001). No correlation was found
between the immunologic impairment and age, primitive renal disease,
duration and schedule of treatment. Our data suggest that in uremic
patients the impaired immune response may be due principally to
functional disorder.
Arteriolar pathology in idiopathic glomerulonephritis. G. Manganella
and D. Turner. Insituto di Antomia Patologica, Universitd, Ban, Italy;
Guy's Hospital, London, United Kingdom. In some renal biopsy
specimens (RB) from patients with idiopathic glomerulonephritis (IG) a
certain amount of vascular damage may be observed as well as the
glomerular and tubulo-interstitial lesions. To establish if some types of
IG are more frequently associated than others with renal arteriolar
damage 304 RB from patients with IG were examined. Araldite (0.5 )
embedded sections stained with toluidine blue were observed by light
microscopy and classified as positive or negative for arteriolar lesions.
The biopsy specimens were subsequently subdivided according to the
type of the IG, the age of the patient, above or under 40 years, and the
presence or absence of hypertension as defined by a persistent diastolic
of 95 mm Hg or more prior to the biopsy. This particular grouping was
used to separate the vascular lesions resulting from aging or hyperten-
sion. The examination of the results reveals that 82.3% of renal biopsy
specimens from normotensive patients under 40 with focal glomerulo-
sclerosis (FGS) were positive for hyaline lesions, which compares with
19.3% positive RB of normotensive patients in the same age and
pressure group affected by other forms of IG and, significantly, with
7.8% of positive normotensive young patients affected by minimal
change glomerulonephritis (MCGN). One might think that the explana-
tion for the greater frequency of hyaline subendothelial lesions in
association with FGS lies in the high levels of serum lipids in the
nephrotic syndrome (NS) associated with this form of IG; however, our
results show that the lesions in question are uncommon in the MCGN
also characterized by a NS with hyperlipidemia. The greater incidence
of subendothelial hyaline deposits in FGS in the absence of hyperten-
sion and aging could explain the higher frequency and importance of the
tubulo-interstitial lesions and the poor prognosis of this type of IG as
compared with the more benign MCGN.
Effects of acetazolamide on calcium (Ca) and phosphate metabolism in
nephrotic syndrome (NS). P. Messa, G. Mioni, M. Adorati, D. Montan-
aro, and M. Messa. Divisione di Nefnologia e Dialisi, Ospedale Civile,
Udine, Italy. To better clarify the pathogenesis of reduced Ca absorp-
tion and hypocalciuria in NS, we studied 21 nephrotic patients (9
women and 12 men, aged 14 to 69 years) who had proteinuria in excess
of 3 g/day (3.4 to 24.5) and normal renal function (Ce. 80 to 147 mI/mm).
TmPi/GFR (measured by infusion methodology), fractional intestinal
absorption of calcium (by double curve analysis), s-V-DBG, s-PTH-
COOH, electrolytes, and acid-base balance in blood and urine were
evaluated. On the basis of TmPi/GFR values, we divided our patients in
two groups: group H (N = 13) with high (>4.4 mg/dl) TmPi/GFR (M
SEM 5.13 0.22) and group N (N = 8) with normal (between 2.2 and 4.4
mg/dl) TmPi/GFR (3.57 0.09). Fractional intestinal absorption of
calcium was significantly lower in group H when compared with group
N (20.4 1.9 vs. 47.6 6.1%, P < 0.001; nv. 30 to 55%); the values of
fractional intestinal absorption of calcium were significantly correlated
with TmPi/GFR values (r = +0.63, P = <0.01). Urinary Ca excretion
also appeared lower in group H (15.6 3.6 vs. 46.1 15.2 mg/day P <
0.05). No significative difference was found regarding s-VDBG, s-PTH,
Ccr, u-Prot, and u-Na. Eleven out of these patients (five of group H and
six of group N) received acetazolamide (ACZ), 250 to 375 mg/day for 12
days; after treatment all the above-mentioned parameters were re-
evaluated. TmPi/GFR significantly fell in all treated patients (base 4.3
0.3, ACZ 3.4 0.1 mg/dl, P < 0.01), although the reduction was more
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evident in group H (3.7 0.12 vs. 5.1 0.26, P <0.01) than in group N
(3.1 0.11 vs. 3.6 0.12. P <0.05). Fractional intestinal absorption of
calcium significantly increased in group H (41.4 3.9 vs. 23.7 3.3,
P < 0.01), whereas no significative change was observed in grotip N
(52.9 6.3 vs. 49 7.4A, P = NS). The variations of intestinal
absorption of calcium resulted well correlated with the variations of
TmPi/GFR (r = +0.72, P < 0.05). ACZ also resulted in a striking
calciuric effect (116.2 20 vs. 32.8 II mg/day, P < 0.01). without any
difference between the two groups; the calciuric effect appeared after 8
days of treatment and seemed poorly related to the sodiuretic and
acidemic effects of ACZ. which appeared after 2 days of treatment, and
seemed closely related to the increase in net acid excretion. These
results suggest that the TmPi/GFR may play in some way a major role in
affecting the levels of intestinal Ca absorption and urinary Ca excretion
in nephrotic syndrome. Acetazolamide, through a reduction in the
TmPi/GFR, may partly correct these metabolic derangements.
Does an increased splanchnic production of glucose contribute to
glucose intolerance in CR!? C'. Rohaudo. G. Deferrari. U. Garihotto. A.
Canepa, G .Sa/vidio, G. Gurreri. and A. Tiziane//o. Cattedra di
Ncfrologia Medico e Servizio di Nefro/ogia, Istituto Scientijico di
Medicina Inferno, Universitd, Genova, ito/v. It is well established that
a decreased peripheral glucose (U) utilization plays a mijor role in U
intolerance frequently observed in chronic renal insufficiency (CR1):
however, it is still controversial if an increased splanchnic production of
U shares some responsibility in U intolerance. To investigate the latter
possibility, U and aminoacid (AA) exchange across the hepatosplanch-
nic bed (HS) in the postabsorptive state was evaluated in six nondiahet-
ic patients with CR! (GFR 16.3 3.4 nil/mm) and in six patients with
normal renal function as controls. Both groups of patients had normal
liver function tests and ate strictly comparable diets. Blood samples
were obtained simultaneously from a peripheral artery and from a
hepatic vein. Blood G was measured enzymatieally and AA by an
automatic analyzer. Hepatic blood flow was estimated by the continu-
ous infusion technique employing Indocyanine green dye. In patients
with CR1 arterial U levels were not different from controls (4.51 0.23
vs. 4.97 0.17 mmoles/liter); HS G production and its ratio to insulin
levels were not significantly changed in comparison with controls (521
92 vs. 693 167 p.moles/min and 38 6 vs. 63 14, respectively).
The sum of the uptakes of the individual gluconeogenic i\A was not
different between the two groups (186 it 19 jrmoles/min in controls and
245 43 in CR!). The ratio of the AA utilized, expressed as U
equivalents, to U produced by the I-IS, showed a tendency to increase in
CR!: thus, in this condition, both G production by the HS and
gluconeogenesis from AA are normal. Furthermore, the normal ratio of
U production to insulin suggests an unmodified hepatic sensitivity to
insulin. These data indicate that U intolerance in CR1 is not the
consequence of an altered U metabolism across the HS and confirm
indirectly the view that U intolerance depends on a peripheral resis-
tence to insulin.
Hematoliquoral changes induced by dialysis. C. Ronco, S. Rio sioli, S.
Chioro,nonte, A. Fobris, M. Feriani. G. D'Andrea, P. Porisen, F.
Pisani, and G. La Greco. Sert'iz.i di Nefro/ogia e di Neurologia,
Ospedo/e S. Bortolo, Vicenzo, Italy. This study has been designed to
investigate the cerebrospinal fittid (CSF) changes induced by dialysis
(HD). Two lumbar punctures (befote and after HD) were performed on
10 consenting patients (eight male, two female, mean age 38.5 years)
maintained by regular intet mittent HD (4 hr x 3/week: I sin2 filter) from
almost I year. CSF and venous blood samples were taken simulta-
neously for SMAC24 and acid-base status determination. CSF prc- and
postdialytic values were, respectively: Na = 154 — 146, K 3.4 2.9.
CI = 120 — 116 mEq/liter: BUN = 72.3 63.7, Creatinine = 4 -- 3.5,
glucose 57 — 56, Ca = 4.3 — 4.2. P 1.7 — 1.6 mg:, osmolalitv =
334 — 328 mOsm/kgH2O: p1-I = 7.35 — 7.35. Pco = 42.2 -- 39.9,
HC01 22.1 — 21.4 mEq/liter. Pre- and postdialytic CSF/plasma
ratios were, respectively: Na = 1.10— 1.05, K = 0.63 0.80, Cl = 1.16
— 1.15, BUN = 0.80— 1.52: creatinine = 0.33 —0.58, Ca (1.5 —((.4. P
= 0.33 —0.46, osmolality -=0.98— 1.0, p1-1 = 0.99 —0.98, Pco, 1.19
— 1.22, HC05 = 1.12 — 0.92. Student's t test for paired data was
applied showing a significant variation in CSF composition and in CSF/
plasma ratios induced by dialysis. A parallel decrease in brain density
(cerebral CT evaluskop) of about 25% from baseline values was
registered. In the meantime, also the trend of plasma and CSF aminoa-
cid (AA) levels was investigated, before and after HD. So. it could be
demonstrated that AA plasma levels change remarkably during the
treatment, while CSF concentrations change scarcely. So CSF/plasma
ratios are influenced by HD: These changes do not correlate with CSF/
plasma ratios regarding the above-mentioned solutes. Neutral, basic.
and acid AA seem to show different changes of CSF/plasma ratios
during dialysis: This could be a new approach to evaluate the dialysis
encephalopathy syndrome.
Calcium and phosphate renal handling and parathyroid activity in
pregnancy. M. Surian, G. Colossi, F. Molberti, A. Aiarni, P. Cosci, G.
Ponloriero, G. Rornbo/a, T. Fogozzi, A. Aro/di, G. Groziani, and L.
Mi,ietli. Servizio di Ernodia/isi. O.'ipeda/e Moggiore, Lodi: Servizi di
Vef rn/n gio, Ospeda/i Niguarda-Ca' Grando e Pa/ic/in ico, Mi/ann,
Italy. During pregnancy there is an increase of calcium (Ca) and
phosphate (P) intestinal absorption due to early elevated I .25(OH)2D5
serum levels. Data on parathyroid activity IPTH) are conflicting: PTH
levels have been found high. normal, or low. Moreover, the role of the
kidney in the change of Ca and P metabolism has not well clarified. We
have performed a longitudinal study in 15 healthy pregnant women on a
free diet and without Ca supplements or any kind of drugs in three
different periods of pregnancy (1:6th to 16th: 2:l7th—28th; 3:29th week—
term) and 3 months after delivery or the end of lactation (C). Serum
ionized calcium (Ca) (1:4.54 0.32 mg/dl; 2:4.4 (1.21; 3:4.4 0.24:
C:4.54 0.22), fractional excretion of Ca (FECa: 1:1.2 0.7%: 2:1
0.6; 3:1.2 0.7, C: 1.3 0.7). plasma P. renal threshold ofP (1:3.5
0.6 ing/dI UFR, 2:3.8 0.6, 3:3.9 0.7. C:3.6 0.6), PTH (COOH-
terminal fragment) (1:1.16 0.48 ng/ml. 2:1.3 (1.6. 3:1.13 0.69, C:l
it 0.38) and urinary excretion of cAMP (1:2.2 0.8 nmoles/dl GFR.
2:2.7 1.3,3:2,7 0.8, C:2.5 I) did not change significantly during
pregnancy. As a consequence of augmented GFR, a significant increase
of Ca filtered load (1:7.1 1.9 mg/nun. 2:8.2 3.3,3:7.2 2.7.
C:5.8 1.5, P < 0.05 and <0.02 in I and 2 versus C) and of urinary Ca
excretion(IJCa/UCr, 1:0.2 it 0.08, 2:11.2 0.09 .3:0.16 0.07, C:0.I3
0.05, P < 0.01 and in I and 2 versus C) was observed. In five
women neither plasma cAMP levels (1.64 0.52 nmoles dl) nor
nephrogenous cAMP production (1.38 0.7 nmoles/dl GFR) were
significantly different from C (1.86 (1.28 and 1. 12 (1.74. respectively)
during gestation. Our data on the basis of normal values of PTH,
urinary cAMP excretion, renal threshold of P and tubular reabsorption
of Ca, evaluated as fractional excretion of Ca', argue against a
"physiologic" hyperparathyroidism in pregnancy, as suggested by
other authors. The augmented UFR is responsible I'or an increase of Ca-
filtered load and, as a consequence. ('or an elevated urinary calcium
excretion, which unmodified is the tubular fractional reabsorption of
calcium.
Acid-base disorders in idiopathic hypercalciuria. N. Tessirore. E.
Va/to, G. Ponzetta. A. Lupo, C. Loschiaro, A. Fabris, L. 0/drizzi. L.
Gorn,noro, C. Rugiu, N. lurino, V. Ortolda, and U. Moschio. Cottedra
e Diti,s lone di NcJio/o,gia Mcdi a, (iso ersiui e is Iii oil (.(spitalieri,
Vc,'ona, ito/v. In view' of the increasing evidence of multiple renal
tubular defects in patients with calcium nephrolithiasis. especially in
those with hyperealciuria. we have evaluated the renal regulation of
acid-base balance in 16 adult patients (II males .5 females) with "renal
leak" hypercalciuria through the oral short N1-14C1 loading-test (0.1 g/kg
body wt) and an intravenous bicarbonate loading-test (NaHCO5 0.5 51
to 5 tnhq/min). All patients had normal GER. concentrating capacity.
plasma potassium, phosphate. and i-P'T'H values and no evidence of
infection or obstruction of the urinary tract. We made diagnosis of
incomplete proximal renal tubular acidosis (RTA) in six patients
(37.5%) according to high HCO fractional excretion at normal plasma
bicarbonate levels (>5%) and reduced 'Fm HCO5 /dl UFR (<2.1 mEq/
dl GFR). Three patients 18.7%) had ineoniplete distal RI-A. according
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to high urinary pH values (5.4) and low ammoniuria (<25 Eq/min)
under NH4CI loading and to the failure to increase the urine-blood Pco2
gradient during bicarbonate infusion (<26 mm Hg). In two of them the
proximal and distal defects were associated. When compared to the
patients with normal acid-base status, the ones with RTA showed
comparable Na, K, Cl, and phosphate renal handling but signifi-
cantly increased basal urinary pH (6.6 0.2 vs. 5.6 0.1) and stone
activity (1.1 vs. 0.5 stones/patient/year): These findings seem to suggest
a pathophysiological role of the acidifying defect in calcium-containing
stone formation, possibly through higher urinary pH values. Under
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bicarbonate loading we found a linear relationship between Na and
Ca fractional excretions in controls as well as in hypercalciurics: In
the two groups the slope was the same (0.40 to 0.45), but the intercept
was different (0.21 and 1.31). This finding suggests a normal renal
tubular handling of calcium in hypercalciuria, even if the urinary
calcium excretion is always set to a higher value. Moreover, no
difference between patients with or without RTA was observed. In
conclusion, our study shows a high incidence of incomplete acidifying
defects, mainly proximal, in renal leak" hypercalciuria and suggests
that these defects are unrelated to the renal calcium handling.
